Boston Scientific: Goldman Sachs starts reporting with a buy rating; target share price is $90
波士顿科学公司：高盛以买入评级启动报道；目标股价为90美元
Boston Scientific: Goldman Sachs starts reporting with a buy rating; target share price is $90
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.